Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Addiction. 2018 Sep 20;113(12):2250–2258. doi: 10.1111/add.14398

Table 1.

Baseline characteristics of 820 people who use drugs and initiated opioid agonist treatment during follow-up, stratified by ≥ daily cannabis use, Vancouver, Canada (1996-2016)

Characteristic Total, n (%)
(N = 820)
≥Daily cannabis use, n (%)*
p - value
Yes
(n = 139)
No
(n = 681)
Socio-demographics
 Age (med, IQR) 38 (30–45) 35 (29–42) 39 (31–46) 0.006
 Male gender 474 (57.8) 93 (67.0) 381 (56.0) 0.017
 Caucasian ethnicity 487 (59.4) 89 (64.0) 398 (58.4) 0.222
 ≥High school education 542 (66.1) 93 (66.9) 449 (65.9) 0.998
 HIV positive 264 (32.2) 46 (33.1) 218 (32.1) 0.804
Substance use-related factors*
 ≥Daily heroin injection 360 (43.9) 57 (41.0) 303 (44.5) 0.426
 ≥Daily prescription opioid use 65 (7.9) 15 (10.8) 50 (7.3) 0.175
 ≥Daily cocaine injection 160 (19.5) 29 (20.9) 131 (19.2) 0.659
 ≥Daily crack use 228 (27.8) 45 (32.3) 183 (26.9) 0.170
 Heavy alcohol use 332 (40.5) 62 (44.6) 270 (39.6) 0.284
Social-structural factors*
 Homeless 187 (22.8) 27 (19.4) 160 (23.5) 0.293
 Incarceration 194 (23.7) 23 (16.5) 171 (25.5) 0.030
Calendar year of OAT initiation
 1996-2000 201 (24.5) 15 (10.8) 186 (27.3)
 2001-2005 232 (28.3) 59 (42.5) 173 (25.4)
 2006-2010 218 (26.6) 27 (19.4) 191 (28.1)
 2011-2016 169 (20.6) 38 (27.3) 131 (19.2)

OAT, opioid agonist therapy

*

Refers to the 6-month period prior to OAT initiation

Wilcoxon rank sum test